Dual inhibition of RNAi therapeutic miR-26a-5p targeting cMet and immunotherapy against EGFR in endometrial cancer treatment

BACKGROUND: Precise prediction of drug combination targeting tumor cells effectively is a crucial challenge for tumor therapy, especially for endometrial cancer (EC). Considering the resistance, crosstalk that occurs between the receptor tyrosine kinase mesenchymal-epithelial transition factor (cMet...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yun, Cai, Yixuan, Chang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859788/
https://www.ncbi.nlm.nih.gov/pubmed/33553298
http://dx.doi.org/10.21037/atm-20-3166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859788/
https://www.ncbi.nlm.nih.gov/pubmed/33553298
http://dx.doi.org/10.21037/atm-20-3166

Ejemplares similares